Lumos Diagnostics Holdings Limited
Lumos Diagnostics Holdings Limited (LDXHF) Financial Performance & Income Statement Overview
Analyze Lumos Diagnostics Holdings Limited (LDXHF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Lumos Diagnostics Holdings Limited (LDXHF) Income Statement & Financial Overview
Analyze Lumos Diagnostics Holdings Limited’s LDXHF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $4.18M | $4.18M | $1.38M | $1.38M |
| Cost of Revenue | $1.62M | $1.62M | $665500.00 | $665500.00 |
| Gross Profit | $2.56M | $2.56M | $717500.00 | $717500.00 |
| Gross Profit Ratio | $0.61 | $0.61 | $0.52 | $0.52 |
| R&D Expenses | $20500.00 | $20500.00 | $55000.00 | $55000.00 |
| SG&A Expenses | $2.90M | $2.90M | $2.85M | $2.85M |
| Operating Expenses | $2.92M | $2.92M | $2.91M | $3.52M |
| Total Costs & Expenses | $4.54M | $4.54M | $3.57M | $4.19M |
| Interest Income | $0.00 | $0.00 | $401000.00 | $401000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $171250.00 | $322166.00 | $624000.00 | $624000.00 |
| EBITDA | -$842250.00 | -$691334.00 | -$2.19M | -$2.19M |
| EBITDA Ratio | -$0.20 | -$0.17 | -$1.58 | -$1.58 |
| Operating Income | -$354000.00 | -$354000.00 | -$2.19M | -$2.81M |
| Operating Income Ratio | -$0.08 | -$0.08 | -$1.58 | -$2.04 |
| Other Income/Expenses (Net) | -$735500.00 | -$735500.00 | -$1.02M | -$391500.00 |
| Income Before Tax | -$1.09M | -$1.09M | -$3.21M | -$3.21M |
| Income Before Tax Ratio | -$0.26 | -$0.26 | -$2.32 | -$2.32 |
| Income Tax Expense | $0.00 | -$659500.00 | -$624000.00 | $0.00 |
| Net Income | -$1.09M | -$1.09M | -$3.21M | -$3.21M |
| Net Income Ratio | -$0.26 | -$0.26 | -$2.32 | -$2.32 |
| EPS | -$0.002 | -$0.002 | -$0.007 | -$0.007 |
| Diluted EPS | -$0.002 | -$0.002 | -$0.007 | -$0.007 |
| Weighted Avg Shares Outstanding | $482.08M | $482.08M | $444.48M | $444.48M |
| Weighted Avg Shares Outstanding (Diluted) | $481.94M | $481.94M | $444.45M | $444.45M |
Over the last four quarters, Lumos Diagnostics Holdings Limited achieved steady financial progress, growing revenue from $1.38M in Q1 2024 to $4.18M in Q4 2024. Gross profit stayed firm with margins at 61% in Q4 2024 versus 52% in Q1 2024. Operating income totaled -$354000.00 in Q4 2024, maintaining a -8% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$842250.00. Net income rose to -$1.09M, with EPS at -$0.002. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan